Infection Control Related Content
COVID-19 symptoms are changing with new variants
A sore throat and hoarse voice were the main COVID-19 symptoms with newer variants – but have symptoms changed as variants get smarter?
Seegene develops monkeypox PCR test
South Korea's leading molecular diagnostics (MDx) company Seegene Inc. has developed a PCR to detect positive cases of monkeypox virus within 90 minutes.
Genomic characterisation for improved responses to dengue outbreaks in Tanzania
Gaspary Mwanyika from the SACIDS Foundation for One Health, Sokoine University of Agriculture, Tanzania details the importance of genomic characterisation in the control of dengue.
People in Republican counties more likely to die from COVID-19
The partisan divide across the United States found that Republican counties suffer from higher mortality rates from the COVID-19 pandemic.
Novacyt is powering ahead and tackling emerging health concerns
Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
Should we be preparing for a widespread monkeypox outbreak?
This ‘unusual’ monkeypox outbreak has been found to be larger and more widespread than previous outbreaks outside of Africa, and health experts propose better preparation.
Estrogen treatment can reduce COVID-19 mortality by 22%
Researchers find that estrogen can reduce the severity of COVID-19 mortality, explaining why fewer women were affected by the disease than men.
SACIDS Foundation for One Health – tackling infectious diseases
As an inter-institutional network dealing with infectious diseases, SACIDS focuses on both individual and institutional development.
Understanding the immune system to create new malaria treatments
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
Inflammation from COVID-19 can cause multi-organ damage
Severe cases of inflammation from COVID-19 can occur in some people – leading to cases of acute respiratory distress and multi-organ damage.
Which is the better protection against COVID-19? Immunity or vaccination?
Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.
Food safety: Over 25% of people cook with raw chicken
Over a quarter of study participants contaminate salad with raw chicken – not washing surfaces efficiently or cooking chicken properly can pose great threats to food safety.
Can mice be an effective model animal for Covid-19?
Examining existing approved compounds to treat Covid-19 can significantly speed up the development of drugs.
Honeybee viral strains & transmission between honeybee colonies
Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.
750,000 fewer dengue cases during COVID-19 closures in 2020
During the height of restrictions and workplace closures for COVID-19, dengue cases dropped across 23 countries in Latin America and Southeast Asia.
Healthcare-associated infections: Cleanliness goes hand in hand with safety
John Brill from Nilfisk outlines how strategic cleaning regimes can support the critical need to ensure healthcare environments provide the highest standards of cleanliness in the fight to prevent healthcare-associated infections.
How do temperature variations affect infectious diseases?
Climate change is set to rise temperatures globally through greenhouse gas emissions, amidst this change, rates of infectious diseases are to become increasingly difficult to predict.
Just 5% of COVID expenditure could prevent the next pandemic
Reducing the risk of future pandemics takes investment, biodiversity action, and fostering better human-wildlife relationships to prevent the spread of zoonotic viruses.
How to compete with COVID-19 with a computer?
Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.
Fluvoxamine can cut COVID-19 hospitalisations by 30%
Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.